BENGALURU (Reuters) – India’s drug regulator on Wednesday granted approval to Bharat Biotech for conducting late-stage trials of its nasal COVID-19 vaccine to be used as a booster shot, according to a Mint report, which cited ANI.
(Reporting by Shivani Singh in Bengaluru; Editing by Shounak Dasgupta)
